Table 2 EBUS-TBNA pathological findings

Absence of pathological findings, N (%)^a

188 (65.5)

Squamous Cell Carcinoma, N (%)

40 (13.9)

Adenocarcinoma, N (%)

38 (13.2)

Large Cell carcinoma, N (%)

1 (0.3)

Adenosquamous Carcinoma, N (%)

1 (0.3)

NSCLC-NOS, N (%)

4 (1.3)

Clear Cell Carcinoma, N (%)

1 (0.3)

Undifferentiated Carcinoma, N (%)

2 (0.7)

Neuroendocrine Tumor, N (%)

1 (0.3)

Thymoma, N (%)

1 (0.3)

Lymphoproliferative Process, N (%)

2 (0.7)

Sarcomatous Process, N (%)

1 (0.3)

Anthracosis and Silica, N (%)

1 (0.3)

Granulomatous Process, N (%)

4 (1.4)

Inflammatory Process, N (%)

2 (0.7)

Total, N (%)

287 (100 %)